DFCM
AVIR icon

Dark Forest Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History

Dark Forest Capital Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31
Closed – – 1144
2022
Q3 		$0 Sell
31
-149
-83% -$1.14K ﹤0.01% 1134
2022
Q2 		$1K Sell
180
-1,733
-91% -$11.8K ﹤0.01% 766
2022
Q1 		$13K Sell
1,913
-26,859
-93% -$182K ﹤0.01% 940
2021
Q4 		$257K Buy
+28,772
New +$448K 0.09% 191

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Dark Forest Capital Management's AVIR Position: Q4 2022 in Review

Dark Forest Capital Management sold out of Atea Pharmaceuticals (AVIR) in Q4 2022, closing a stake of 31 shares.

Dark Forest Capital Management first reported a position in AVIR in Q4 2021 and held it in 4 quarters. The position peaked at $257K in Q4 2021. 131 funds tracked by Wall St. Rank hold AVIR as of Q4 2022.

  • Dark Forest Capital Management reported no remaining Atea Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 31 Atea Pharmaceuticals shares in Q4 2022.
  • Dark Forest Capital Management first reported a position in Atea Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Atea Pharmaceuticals position peaked at $257K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2022.

Based on Dark Forest Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.